Drug combination benefits patients with tophaceous gout

June 9, 2017, Wiley

The drug lesinurad in combination with febuxostat was better at lowering blood levels of urate than febuxostat alone in a phase III clinical trial of 324 patients with tophaceous gout. Over 12 months, significantly more patients in the combination group achieved target levels of urate than patients in the febuxostat group.

Gout occurs when urate crystals accumulate in the joints, causing inflammation and intense pain. In some people, large deposits of urate crystals (tophi) form. These deposits can cause chronic joint inflammation and damage. Current guidelines for long-term treatment of gout recommend urate-lowering therapy to maintain a blood urate level below 5.0 mg/dl in patients with tophaceous gout. The recommended first-line urate-lowering therapy is a xanthine oxidase inhibitor, either allopurinol or febuxostat, which inhibits urate production. Many patients are unable to achieve a urate level of <5.0 mg/dl with these drugs, however.

Lesinurad inhibits a uric acid transporter in the kidney and increases excretion of uric acid in the urine. Therefore, lesinurad in combination with a xanthine oxidase inhibitor provides a dual mechanism of action to lower of urate by increasing kidney excretion of uric acid and reducing urate production.

"Combination treatment of lesinurad and febuxostat represents a new therapeutic option for with severe who cannot achieve the serum urate treatment target with xanthine oxidase inhibitor monotherapy," said Prof. Nicola Dalbeth, lead author of the Arthritis & Rheumatology trial.

Explore further: Urate-lowering therapy helps chronic kidney disease patients improve organ function

More information: Nicola Dalbeth et al. Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: A Phase III Clinical Trial, Arthritis & Rheumatology (2017). DOI: 10.1002/art.40159

Related Stories

Urate-lowering therapy helps chronic kidney disease patients improve organ function

November 13, 2016
Chronic kidney disease patients who take urate-lowering therapy and achieve target urate levels show improvement in kidney function, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meeting ...

Vitamin C does not lower uric acid levels in gout patients

May 16, 2013
Despite previous studies touting its benefit in moderating gout risk, new research reveals that vitamin C, also known ascorbic acid, does not reduce uric acid (urate) levels to a clinically significant degree in patients ...

Many patients with gout do not receive recommended treatment

December 23, 2014
Among patients in England with gout, only a minority of those with indications to receive urate-lowering therapy were treated according to guideline recommendations, according to a study in the December 24/31 issue of JAMA.

High levels of urate in blood associated with lower risk of Parkinson's disease

January 13, 2016
Men who have high levels of urate, also known as uric acid, in their blood may be less likely to develop Parkinson's disease, according to a study published in the Jan. 13, 2016, online issue of Neurology, the medical journal ...

Dual-energy CT may be useful in evaluating the severity of gout, study suggests

April 30, 2011
The incidence of gout is on the rise and duel energy CT has the potential to allow non-invasive diagnosis of the disease, according to radiologists at the University of British Columbia, Vancouver General Hospital, in Vancouver, ...

Recommended for you

Researchers watch the knee degenerate and understand how osteoarthritis may begin

December 12, 2018
For hockey great Bobby Orr, a torn knee ligament ended his career at age 30. Orr had more than 17 knee operations, at one point having his meniscus removed—the cartilaginous tissue that helps stabilize and lubricate the ...

3-D printing offers helping hand to people with arthritis

December 11, 2018
Adaptive aids are expensive. Additive manufacturing, using low-cost 3-D printers, can save upwards of 94 percent for simple household items.

Potential arthritis treatment prevents cartilage breakdown

November 28, 2018
Osteoarthritis, a disease that causes severe joint pain, affects more than 20 million people in the United States. Some drug treatments can help alleviate the pain, but there are no treatments that can reverse or slow the ...

Patchy distribution of joint inflammation resolved

November 16, 2018
Chronic inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and spondylo-arthritis (SpA) are chronic, disabling diseases with a poor outcome for loco-motoric function if left untreated. RA and SpA each affect ...

Defense against joint degeneration

October 30, 2018
During cartilage development, chondrocytes secrete the extracellular matrix (ECM) and embed within the same environment. During progressive joint disease, such as osteoarthritis (OA), dysregulation of the process can lead ...

Becoming more sensitive to pain increases the risk of knee pain not going away

October 30, 2018
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis, according to a new study by researchers at Université de Montréal and its affiliated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.